CareDx (CDNA) Gross Profit (2013 - 2026)

CareDx (CDNA) has 14 years of Gross Profit data on file, last reported at $87.3 million in Q1 2026.

• Quarterly Gross Profit rose 41.55% year-over-year to $87.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $302.8 million (up 15.89% YoY) and the FY2025 annual result came in at $277.2 million, up 10.07% from the prior year.
• Gross Profit advanced to $87.3 million in Q1 2026 per CDNA's latest filing, from $77.5 million in the prior quarter.
• The five-year high for Gross Profit was $87.3 million in Q1 2026, with the low at $44.8 million in Q4 2023.
• Average Gross Profit over 5 years is $61.1 million, with a median of $58.7 million recorded in 2022.
• Year-over-year, Gross Profit retreated 23.63% in 2023 and surged 46.44% in 2024.
• CareDx's Gross Profit stood at $58.7 million in 2022, then dropped by 23.63% to $44.8 million in 2023, then surged by 45.48% to $65.2 million in 2024, then gained by 18.74% to $77.5 million in 2025, then climbed by 12.74% to $87.3 million in 2026.
• Business Quant data shows CDNA's Gross Profit at $87.3 million in Q1 2026, $77.5 million in Q4 2025, and $75.6 million in Q3 2025.